Biessels GJ - Search Results

1

Cognition and diabetes: a lifespan perspective.

Biessels GJ, Deary IJ, Ryan CM. Biessels GJ, et al. Lancet Neurol. 2008 Feb;7(2):184-90. doi: 10.1016/S1474-4422(08)70021-8. Lancet Neurol. 2008. PMID: 18207116 Review.

2

Ageing and diabetes: implications for brain function.

Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH. Biessels GJ, et al. Eur J Pharmacol. 2002 Apr 19;441(1-2):1-14. doi: 10.1016/s0014-2999(02)01486-3. Eur J Pharmacol. 2002. PMID: 12007915 Review.

3

Neuronal Ca2+ disregulation in diabetes mellitus.

Biessels GJ, ter Laak MP, Hamers FP, Gispen WH. Biessels GJ, et al. Eur J Pharmacol. 2002 Jul 5;447(2-3):201-9. doi: 10.1016/s0014-2999(02)01844-7. Eur J Pharmacol. 2002. PMID: 12151012

4

Effects of a phorbol ester and cyclosporin A on hippocampal synaptic plasticity in streptozotocin-induced-diabetic rats: reduced sensitivity to phorbol esters.

Kamal A, Ramakers GM, Biessels GJ, Gispen WH. Kamal A, et al. Among authors: biessels gj. Neurosci Lett. 2003 Mar 13;339(1):45-8. doi: 10.1016/s0304-3940(02)01451-9. Neurosci Lett. 2003. PMID: 12618297

5

Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats.

Manschot SM, Biessels GJ, Cameron NE, Cotter MA, Kamal A, Kappelle LJ, Gispen WH. Manschot SM, et al. Among authors: biessels gj. Brain Res. 2003 Mar 21;966(2):274-82. doi: 10.1016/s0006-8993(02)04211-7. Brain Res. 2003. PMID: 12618350

6

Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.

Manschot SM, Gispen WH, Kappelle LJ, Biessels GJ. Manschot SM, et al. Among authors: biessels gj. Diabetes Metab Res Rev. 2003 Nov-Dec;19(6):469-77. doi: 10.1002/dmrr.401. Diabetes Metab Res Rev. 2003. PMID: 14648806

7

Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface.

Biessels GJ, Bravenboer B, Gispen WH. Biessels GJ, et al. Eur J Pharmacol. 2004 Apr 19;490(1-3):1-4. doi: 10.1016/j.ejphar.2004.02.057. Eur J Pharmacol. 2004. PMID: 15094068

8

Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels.

Brands AM, Kessels RP, de Haan EH, Kappelle LJ, Biessels GJ. Brands AM, et al. Among authors: biessels gj. Eur J Pharmacol. 2004 Apr 19;490(1-3):159-68. doi: 10.1016/j.ejphar.2004.02.053. Eur J Pharmacol. 2004. PMID: 15094082 Review.

9

Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.

Biessels GJ, ter Laak MP, Kamal A, Gispen WH. Biessels GJ, et al. Brain Res. 2005 Feb 21;1035(1):86-93. doi: 10.1016/j.brainres.2004.12.025. Brain Res. 2005. PMID: 15713280

10

The effects of type 1 diabetes on cognitive performance: a meta-analysis.

Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP. Brands AM, et al. Among authors: biessels gj. Diabetes Care. 2005 Mar;28(3):726-35. doi: 10.2337/diacare.28.3.726. Diabetes Care. 2005. PMID: 15735218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results